| Vol. 9.10 – 16 March, 2021 |
| |
|
|
| The authors characterized the single-cell transcriptomes of cancer and immune cells from metastatic renal cell carcinoma patients before or after immune checkpoint blockade exposure. [Cancer Cell] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| To understand the metabolic state of rare, early-activated T cells, scientists adapted mass cytometry to quantify metabolic regulators at single-cell resolution in parallel with cell signaling, proliferation, and effector function. [Immunity] |
|
|
|
| Investigators describe an approach to target T cell cancers through T cell receptor (TCR) antigens. Each T cell, normal or malignant, expressed a unique TCR β chain generated from 1 of 30 TCR β chain variable gene families. [Science Translational Medicine] |
|
|
|
| Scientists combined single-cell RNA-sequencing and multiparameter flow cytometry to assess changes in circulating CD8+ T cells in 28 patients with metastatic melanoma starting anti-PD-1 therapy. [Nature Communications] |
|
|
|
| The authors found T-cell exhaustion linked to overall survival in 675 hepatocellular carcinoma patients with diverse ethnicities and etiologies. [Nature Communications] |
|
|
|
| Researchers qualitatively and quantitatively studied the main players in PINK1-mediated mitophagy in peripheral blood mononuclear cells of patients with relapsing–remitting multiple sclerosis. [Cell Death & Differentiation] |
|
|
|
| Researchers demonstrated that interleukin-32 (IL-32) expression was significantly upregulated in syncytiotrophoblasts and that IL-32β was the major isoform with increased expression in the placenta of severe preeclampsia patients. [Cellular & Molecular Immunology] |
|
|
|
| Researchers identified effector memory CD4+ T cells and CD4–CD8low/-CD161+ T cells, specifically those positive for the chemokine receptor CCR6, as the circulating immune subtypes with the greatest response to IL-1β. [Science Signaling] |
|
|
|
| Nucleotide-binding domain–like receptor protein 3 (NLRP3) knockout and rescue experiments demonstrated that NLRP3 participated in protectin DX-mediated Treg/Th17 cell balance restoration, joint injury amelioration and inflammatory-response attenuation using Nlrp3-/- mice. [Cell Death & Disease] |
|
|
|
| PI3K∂ blockade by idelalisib reduced the expression levels of inhibitory checkpoint molecules in T cells isolated from both healthy donors and chronic lymphocytic leukemia patients. [Frontiers in Immunology] |
|
|
|
| Scientists hypothesized that adding acetylsalicylic acid and low-dose interleukin-2 would increase the vaccine efficacy in a recurrent advanced ovarian cancer Phase I trial. [npj Vaccines] |
|
|
|
| Researchers studied the proportion of different B cell subsets and their capacity to secrete IL-10 ex vivo in peripheral blood from patients with or without chronic Chagas disease cardiomyopathy. [Scientific Reports] |
|
|
|
|
| Scientists review the tumor-derived factors modulating dendritic cell function. [Nature Reviews Cancer] |
|
|
|
| The authors review the underlying immunological basis of various asthma endotypes by discussing results obtained from animal studies as well as results generated in clinical studies targeting specific immune pathways. [Cell] |
|
|
|
| Scientists cover the mechanisms of NLRP3 inflammasome activation and its divergent roles in the pathogenesis of inflammation-associated diseases such as cancer, atherosclerosis, diabetes and obesity [Nature Immunology] |
|
|
|
|
| 108Labs announced the discovery of novel secretory antibody biosynthesis in the development of Colostrupedicsâ„¢ whole-human infant formula, the first animal-free infant formula exclusively comprising cell-cultured human milk molecules derived from human mammary cell agriculture and formulated with broadly-neutralizing human secretory antibodies. [108Labs (Life Science Newswire, Inc.)] |
|
|
|
| Pathios Therapeutics will team up with researchers at The University of Oxford to accelerate cancer immunotherapies targeting GPR65 on immunosuppressive macrophages [Pathios Therapeutics (Life Science Newswire, Inc.)] |
|
|
|
|
| March 25 – 26, 2021 Virtual |
|
|
|
|
|
| Translate Bio – Lexington, Massachusetts, United States |
|
|
|
| University of Toronto – Toronto, Canada |
|
|
|
| Dana-Farber Cancer Institute – Boston, Massachusetts, United States |
|
|
|
| H. Lee Moffitt Cancer Center & Research Institute – Tampa, Florida, United States |
|
|
|
| Oklahoma Medical Research Foundation – Oklahoma City, Oklahoma, United States |
|
|
|
|